Literature DB >> 19912324

Association of the MAPT locus with Parkinson's disease.

C Wider1, C Vilariño-Güell, B Jasinska-Myga, M G Heckman, A I Soto-Ortolaza, S A Cobb, J O Aasly, J M Gibson, T Lynch, R J Uitti, Z K Wszolek, M J Farrer, O A Ross.   

Abstract

BACKGROUND AND
PURPOSE: Whilst an association between the tau gene (MAPT)-containing H1 haplotype and supranuclear gaze palsy (PSP) has long been recognized, the effect of H1 on risk for Parkinson's disease (PD) has remained more contentious.
METHODS: Herein, we examined the association of H1 and PD in three Caucasian PD patient-control series from Ireland, Norway, and the US (combined: n = 2619), by genotyping two H1/H2 single nucleotide polymorphisms (SNPs) in MAPT (rs1052553) and in the Saitohin gene (rs62063857) and one H1-specific SNP (rs242557).
RESULTS: We identified a significant association between H1/H2 and risk of PD (rs1052553 OR: 1.43, CI: 1.23-1.64; rs62063857 OR: 1.45, CI: 1.27-1.67), but no effect of the H1-specific SNP rs242557 (OR: 0.92, CI: 0.82-1.03).
CONCLUSIONS: Our findings show that the H1 haplotype is a significant risk factor for PD. However, one H1-specific SNP (rs242557) previously implicated in PSP did not alter the risk of PD, indicating that distinct H1 sub-haplotypes probably drive the associations with PD and PSP.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19912324      PMCID: PMC3906622          DOI: 10.1111/j.1468-1331.2009.02847.x

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN: 1351-5101            Impact factor:   6.089


  26 in total

1.  Score tests for association between traits and haplotypes when linkage phase is ambiguous.

Authors:  Daniel J Schaid; Charles M Rowland; David E Tines; Robert M Jacobson; Gregory A Poland
Journal:  Am J Hum Genet       Date:  2001-12-27       Impact factor: 11.025

2.  Progressive supranuclear palsy as a disease phenotype caused by the S305S tau gene mutation.

Authors:  Z K Wszolek; Y Tsuboi; R J Uitti; L Reed; M L Hutton; D W Dickson
Journal:  Brain       Date:  2001-08       Impact factor: 13.501

3.  Strong association of the Saitohin gene Q7 variant with progressive supranuclear palsy.

Authors:  R de Silva; A Hope; A Pittman; M E Weale; H R Morris; N W Wood; A J Lees
Journal:  Neurology       Date:  2003-08-12       Impact factor: 9.910

4.  The tau H2 haplotype is almost exclusively Caucasian in origin.

Authors:  Whitney Evans; Hon Chung Fung; John Steele; Johanna Eerola; Pentti Tienari; Alan Pittman; Rohan de Silva; Amanda Myers; Fabienne Wavrant-De Vrieze; Andrew Singleton; John Hardy
Journal:  Neurosci Lett       Date:  2004-10-21       Impact factor: 3.046

5.  The tau H1 haplotype is associated with Parkinson's disease in the Norwegian population.

Authors:  Matt Farrer; Lisa Skipper; Marianne Berg; Gina Bisceglio; Melissa Hanson; John Hardy; Amanda Adam; Katrina Gwinn-Hardy; Jan Aasly
Journal:  Neurosci Lett       Date:  2002-04-05       Impact factor: 3.046

6.  Initiation and synergistic fibrillization of tau and alpha-synuclein.

Authors:  Benoit I Giasson; Mark S Forman; Makoto Higuchi; Lawrence I Golbe; Charles L Graves; Paul T Kotzbauer; John Q Trojanowski; Virginia M-Y Lee
Journal:  Science       Date:  2003-04-25       Impact factor: 47.728

7.  The tau locus is not significantly associated with pathologically confirmed sporadic Parkinson's disease.

Authors:  Rohan de Silva; John Hardy; Julia Crook; Naheed Khan; Elizabeth A Graham; Christopher M Morris; Nicholas W Wood; Andrew J Lees
Journal:  Neurosci Lett       Date:  2002-09-20       Impact factor: 3.046

8.  Linkage disequilibrium and association of MAPT H1 in Parkinson disease.

Authors:  Lisa Skipper; Kristen Wilkes; Mathias Toft; Matthew Baker; Sarah Lincoln; Mary Hulihan; Owen A Ross; Mike Hutton; Jan Aasly; Matthew Farrer
Journal:  Am J Hum Genet       Date:  2004-08-03       Impact factor: 11.025

9.  Autosomal dominant parkinsonism associated with variable synuclein and tau pathology.

Authors:  Z K Wszolek; R F Pfeiffer; Y Tsuboi; R J Uitti; R D McComb; A J Stoessl; A J Strongosky; A Zimprich; B Müller-Myhsok; M J Farrer; T Gasser; D B Calne; D W Dickson
Journal:  Neurology       Date:  2004-05-11       Impact factor: 9.910

10.  Concurrence of alpha-synuclein and tau brain pathology in the Contursi kindred.

Authors:  John E Duda; Benoit I Giasson; Meghann E Mabon; Douglas C Miller; Lawrence I Golbe; Virginia M-Y Lee; John Q Trojanowski
Journal:  Acta Neuropathol       Date:  2002-04-27       Impact factor: 17.088

View more
  33 in total

1.  An evaluation of the impact of MAPT, SNCA and APOE on the burden of Alzheimer's and Lewy body pathology.

Authors:  Christian Wider; Owen A Ross; Kenya Nishioka; Michael G Heckman; Carles Vilariño-Güell; Barbara Jasinska-Myga; Nilufer Erketin-Taner; Rosa Rademakers; Neill R Graff-Radford; Deborah C Mash; Spiridon Papapetropoulos; Ranjan Duara; Hirotake Uchikado; Zbigniew K Wszolek; Matthew J Farrer; Dennis W Dickson
Journal:  J Neurol Neurosurg Psychiatry       Date:  2012-01-30       Impact factor: 10.154

2.  Structural and functional characterization of H2 haplotype MAPT promoter: unique neurospecific domains and a hypoxia-inducible element would enhance rationally targeted tauopathy research for Alzheimer's disease.

Authors:  Bryan Maloney; Debomoy K Lahiri
Journal:  Gene       Date:  2012-01-30       Impact factor: 3.688

3.  MAPT H1 haplotype is a risk factor for essential tremor and multiple system atrophy.

Authors:  C Vilariño-Güell; A I Soto-Ortolaza; A Rajput; D C Mash; S Papapetropoulos; R Pahwa; K E Lyons; R J Uitti; Z K Wszolek; D W Dickson; M J Farrer; O A Ross
Journal:  Neurology       Date:  2011-02-15       Impact factor: 9.910

4.  Polymorphic genes of detoxification and mitochondrial enzymes and risk for progressive supranuclear palsy: a case control study.

Authors:  Lisa F Potts; Alex C Cambon; Owen A Ross; Rosa Rademakers; Dennis W Dickson; Ryan J Uitti; Zbigniew K Wszolek; Shesh N Rai; Matthew J Farrer; David W Hein; Irene Litvan
Journal:  BMC Med Genet       Date:  2012-03-17       Impact factor: 2.103

5.  Sequence variants in eukaryotic translation initiation factor 4-gamma (eIF4G1) are associated with Lewy body dementia.

Authors:  Shinsuke Fujioka; Christina Sundal; Audrey J Strongosky; Monica Case Castanedes; Rosa Rademakers; Owen A Ross; Carles Vilariño-Güell; Matthew J Farrer; Zbigniew K Wszolek; Dennis W Dickson
Journal:  Acta Neuropathol       Date:  2012-11-04       Impact factor: 17.088

6.  LINGO1 and LINGO2 variants are associated with essential tremor and Parkinson disease.

Authors:  Carles Vilariño-Güell; Christian Wider; Owen A Ross; Barbara Jasinska-Myga; Jennifer Kachergus; Stephanie A Cobb; Alexandra I Soto-Ortolaza; Bahareh Behrouz; Michael G Heckman; Nancy N Diehl; Claudia M Testa; Zbigniew K Wszolek; Ryan J Uitti; Joseph Jankovic; Elan D Louis; Lorraine N Clark; Alex Rajput; Matthew J Farrer
Journal:  Neurogenetics       Date:  2010-04-06       Impact factor: 2.660

7.  Identification of Parkinson's disease candidate genes using CAESAR and screening of MAPT and SNCAIP in South African Parkinson's disease patients.

Authors:  Rowena J Keyser; Ekow Oppon; Jonathan A Carr; Soraya Bardien
Journal:  J Neural Transm (Vienna)       Date:  2011-02-23       Impact factor: 3.575

8.  Saitohin, which is nested within the tau gene, interacts with tau and Abl and its human-specific allele influences Abl phosphorylation.

Authors:  Yan Wang; Lei Gao; Christopher G Conrad; Athena Andreadis
Journal:  J Cell Biochem       Date:  2011-11       Impact factor: 4.429

Review 9.  It's all about tau.

Authors:  Cheril Tapia-Rojas; Fabian Cabezas-Opazo; Carol A Deaton; Erick H Vergara; Gail V W Johnson; Rodrigo A Quintanilla
Journal:  Prog Neurobiol       Date:  2018-12-31       Impact factor: 11.685

10.  Protective effect of LRRK2 p.R1398H on risk of Parkinson's disease is independent of MAPT and SNCA variants.

Authors:  Michael G Heckman; Alexis Elbaz; Alexandra I Soto-Ortolaza; Daniel J Serie; Jan O Aasly; Grazia Annesi; Georg Auburger; Justin A Bacon; Magdalena Boczarska-Jedynak; Maria Bozi; Laura Brighina; Marie-Christine Chartier-Harlin; Efthimios Dardiotis; Alain Destée; Carlo Ferrarese; Alessandro Ferraris; Brian Fiske; Suzana Gispert; Georgios M Hadjigeorgiou; Nobutaka Hattori; John P A Ioannidis; Barbara Jasinska-Myga; Beom S Jeon; Yun Joong Kim; Christine Klein; Rejko Kruger; Elli Kyratzi; Chin-Hsien Lin; Katja Lohmann; Marie-Anne Loriot; Timothy Lynch; George D Mellick; Eugénie Mutez; Grzegorz Opala; Sung Sup Park; Simona Petrucci; Aldo Quattrone; Manu Sharma; Peter A Silburn; Young Ho Sohn; Leonidas Stefanis; Vera Tadic; Hiroyuki Tomiyama; Ryan J Uitti; Enza Maria Valente; Demetrios K Vassilatis; Carles Vilariño-Güell; Linda R White; Karin Wirdefeldt; Zbigniew K Wszolek; Ruey-Meei Wu; Georgia Xiromerisiou; Demetrius M Maraganore; Matthew J Farrer; Owen A Ross
Journal:  Neurobiol Aging       Date:  2013-08-17       Impact factor: 4.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.